Vitamin K

 Vitamin K is best known for its beneficial effects on blood clotting and bone.

Vitamin K is a fat-soluble vitamin best known for its regulation of proper blood clotting and its significant role in bone health. 1

The term “vitamin K” actually refers to a family of related substances called naphthoquinones, in which there are two sub-types, known as vitamin K1 and vitamin K2.

Vitamin K1
Alternate names: Phylloquinone, phytomenadione, and phytonadione.
Vitamin K1 is made by plants such as green leafy vegetables, olive oil, soy beans, brussel sprouts, broccoli, cauliflower, coffee, and green tea.
Vitamin K2
Alternate names: Menaquinone and menatetrenone.
“Vitamin K2” is a term that also encompasses different sub-types, of which MK-4 and MK-7 are the two most commonly found in supplements.

MK-4
Naturally synthesized from vitamin K1 by animals.
Sources are various meats and egg yolks.
MK-7 (also MK-8 and MK-9)
Produced in the human gastro-intestinal tract (though not absorbed).
Sources are bacterially-fermented foods such as natto and cheese.

 

Benefits of vitamin K

 Green, leafy and cruciferous veggies are a food source for vitamin K1.

Research is uncovering a role for vitamin K in such a wide array of physiological processes that interest in the vitamin is rapidly growing among the scientific community. 23

Preliminary evidence indicates a protective role for vitamin K in the following:

  • arterial calcification, atherogenesis, and cardiovascular disease 345
  • bone loss and fractures 367891011
  • prostate cancer 121314
  • liver cancer 315161718
  • lung cancer 1920
  • leukemia 2122
  • Alzheimer’s 2223

Vitamin K also shows promise as a potent antibacterial agent 24 and may have a role in regulating energy metabolism and inflammation. 2526

Vitamins K2 and D3

When supplementing with vitamin D, your body’s ability to absorb calcium is greatly enhanced. Since many people already receive a good amount of calcium through diet – with some people supplementing calcium in addition – an optimal vitamin K intake is essential when supplementing with vitamin D.

Vitamin K-dependent proteins in the body act as potent inhibitors of vascular calcification. So adequate vitamin K will help to ensure calcium ends up in bone where it belongs, instead of calcifying various soft tissues. 2728293031

Bone health benefits from both vitamin D and K as they work together, aiding in proper bone formation and maintaining bone density. 5323334 Both BMD and bone mineral content (BMC) have exhibited significant and sustained increase. 3536

Supplementary vitamin K

 Cheese is a great source for vitamin K2 MK-7, with Swiss Cheese having the highest amount.

Daily needs

Unlike other fat-soluble nutrients, vitamin K is not stored in the body and must be received daily through diet or supplementation. In fact, research indicates one can become deficient in vitamin K in as little as 7 days. 37

In 2000 the National Academy of Sciences established the following Adequate Intake (AI) levels for vitamin K:

  • Children under 1 years: 2- 2.5 mcg
  • Children 1-3 years: 30 mcg
  • Children 4-13 years: 55-60 mcg
  • Adolescents 14-18 years: 75 mcg
  • Adult males: 120 mcg
  • Adult females: 90 mcg
  • Pregnant or lactating females: 75-90 mcg

Vitamin K needs increase with age. Older individuals will require larger amounts of vitamin K than will younger adults. 38

Due to increasing awareness of vitamin K’s beneficial health effects, many scientists are now suggesting the recommended intake be increased. 303940

Which vitamin K should I use?

While research indicates both vitamin K1 and K2 have beneficial actions in the body, it is vitamin K2 that is indicated as a necessary co-factor for vitamin D. However, the jury is still out as to the various actions by MK-4 and MK-7 in the body, and which one, if either, is more essential to health.

Vitamin K deficiency

Just as most people get only enough vitamin D to provide protection against rickets and not the more serious conditions vitamin D can protect against, most people get enough K to maintain adequate blood clotting, but not enough to confer protection against conditions such as arterial calcification. 4142

Vitamin K deficiency symptoms

  • easy bruising
  • nosebleeds
  • bleeding gums
  • blood in the urine and stools
  • extremely heavy menstrual bleeding

Vitamin K1 insufficiency in bone has been shown to increase risk of vertebral fracture independently from BMD. 43

Lack of sufficient vitamin K2, can cause the cells lining blood vessel walls to act like bone cells, i.e., absorb calcium. 44

Vitamin K toxicity

No adverse effects have been reported for vitamin K – whether from food or supplements – and so there are no documented toxicity symptoms. There currently is no Upper Limit established for vitamin K.

Contraindications

It is generally recommended to avoid vitamin K altogether when using blood-thinning drugs such as Warfarin or Coumadin. However, studies have found vitamin K2 to be an effective stabilizer in anticoagulant therapy, proving beneficial in situations of over-anticoagulation or when the response to therapy has been variable. 4546474849

Page last edited: 08 August 2011

References

  1. Hara, K. Akiyama, Y. [Vitamin K and bone quality]. Clin Calcium. 2007 Nov; 17 (11): 1678-84.
  2. Kaneki, M. Hosoi, T. Ouchi, Y. Orimo, H. Pleiotropic actions of vitamin K: protector of bone health and beyond?. Nutrition. 2006 Jul-Aug; 22 (7-8): 845-52.
  3. Kaneki, M. [Vitamin K2 as a protector of bone health and beyond]. Clin Calcium. 2005 Apr; 15 (4): 605-10.
  4. Beulens, J. W. Bots, M. L. Atsma, F. Bartelink, M. L. Prokop, M. Geleijnse, J. M. Witteman, J. C. Grobbee, D. E. van der Schouw, Y. T. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009 Apr; 203 (2): 489-93.
  5. Adams, J. Pepping, J. Vitamin K in the treatment and prevention of osteoporosis and arterial calcification. Am J Health Syst Pharm. 2005 Aug 1; 62 (15): 1574-81.
  6. Ishida, Y. [Vitamin K2]. Clin Calcium. 2008 Oct; 18 (10): 1476-82.
  7. Koitaya, N. Ezaki, J. Nishimuta, M. Yamauchi, J. Hashizume, E. Morishita, K. Miyachi, M. Sasaki, S. Ishimi, Y. Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women. J Nutr Sci Vitaminol (Tokyo). 2009 Feb; 55 (1): 15-21.
  8. Cheung, A. M. Tile, L. Lee, Y. Tomlinson, G. Hawker, G. Scher, J. Hu, H. Vieth, R. Thompson, L. Jamal, S. Josse, R. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med. 2008 Oct 14; 5 (10): e196.
  9. Cockayne, S. Adamson, J. Lanham-New, S. Shearer, M. J. Gilbody, S. Torgerson, D. J. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006 Jun 26; 166 (12): 1256-61.
  10. Hosoi, T. [Treatment of primary osteoporosis with vitamin K2]. Clin Calcium. 2007 Nov; 17 (11): 1727-30.
  11. Ochiai, M. Nakashima, A. Takasugi, N. Kiribayashi, K. Kawai, T. Usui, K. Shigemoto, K. Hamaguchi, N. Kohno, N. Yorioka, N. Vitamin K(2) Alters Bone Metabolism Markers in Hemodialysis Patients with a Low Serum Parathyroid Hormone Level. Nephron Clin Pract. 2010 Aug 3; 117 (1): c15-c19.
  12. Nimptsch, K. Rohrmann, S. Kaaks, R. Linseisen, J. Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr. 2010 May; 91 (5): 1348-58.
  13. Tomasetti, M. Strafella, E. Staffolani, S. Santarelli, L. Neuzil, J. Guerrieri, R. alpha-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate. Br J Cancer. 2010 Apr 13; 102 (8): 1224-34.
  14. Nimptsch, K. Rohrmann, S. Nieters, A. Linseisen, J. Serum undercarboxylated osteocalcin as biomarker of vitamin K intake and risk of prostate cancer: a nested case-control study in the Heidelberg cohort of the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18 (1): 49-56.
  15. Kuriyama, S. Hitomi, M. Yoshiji, H. Nonomura, T. Tsujimoto, T. Mitoro, A. Akahane, T. Ogawa, M. Nakai, S. Deguchi, A. Masaki, T. Uchida, N. Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules. Int J Oncol. 2005 Aug; 27 (2): 505-11.
  16. Hitomi, M. Yokoyama, F. Kita, Y. Nonomura, T. Masaki, T. Yoshiji, H. Inoue, H. Kinekawa, F. Kurokohchi, K. Uchida, N. Watanabe, S. Kuriyama, S. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. Int J Oncol. 2005 Mar; 26 (3): 713-20.
  17. Mizuta, T. Ozaki, I. Hepatocellular carcinoma and vitamin K. Vitam Horm. 2008; 78435-42.
  18. Mizuta, T. Ozaki, I. [Clinical application of vitamin K for hepatocellular carcinoma]. Clin Calcium. 2007 Nov; 17 (11): 1693-9.
  19. Yoshida, T. Miyazawa, K. Kasuga, I. Yokoyama, T. Minemura, K. Ustumi, K. Aoshima, M. Ohyashiki, K. Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer. Int J Oncol. 2003 Sep; 23 (3): 627-32.
  20. Yokoyama, T. Miyazawa, K. Yoshida, T. Ohyashiki, K. Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines. Int J Oncol. 2005 Jan; 26 (1): 33-40.
  21. Miyazawa, K. Yaguchi, M. Funato, K. Gotoh, A. Kawanishi, Y. Nishizawa, Y. Yuo, A. Ohyashiki, K. Apoptosis/differentiation-inducing effects of vitamin K2 on HL-60 cells: dichotomous nature of vitamin K2 in leukemia cells. Leukemia. 2001 Jul; 15 (7): 1111-7.
  22. Presse, N. Shatenstein, B. Kergoat, M. J. Ferland, G. Low vitamin K intakes in community-dwelling elders at an early stage of Alzheimer’s disease. J Am Diet Assoc. 2008 Dec; 108 (12): 2095-9.
  23. Allison, A. C. The possible role of vitamin K deficiency in the pathogenesis of Alzheimer’s disease and in augmenting brain damage associated with cardiovascular disease. Med Hypotheses. 2001 Aug; 57 (2): 151-5.
  24. Kurosu, M. Begari, E. Vitamin K2 in electron transport system: are enzymes involved in vitamin K2 biosynthesis promising drug targets?. Molecules. 2010; 15 (3): 1531-53.
  25. Booth, S. L. Roles for vitamin K beyond coagulation. Annu Rev Nutr. 2009; 2989-110.
  26. Shea, M. K. Booth, S. L. Massaro, J. M. Jacques, P. F. D’Agostino, R. B., Sr. Dawson-Hughes, B. Ordovas, J. M. O’Donnell, C. J. Kathiresan, S. Keaney, J. F., Jr. Vasan, R. S. Benjamin, E. J. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol. 2008 Feb 1; 167 (3): 313-20.
  27. Schurgers, L. J. Cranenburg, E. C. Vermeer, C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost. 2008 Oct; 100 (4): 593-603.
  28. Fodor, D. Albu, A. Poanta, L. Porojan, M. Vitamin K and vascular calcifications. Acta Physiol Hung. 2010 Sep; 97 (3): 256-66.
  29. Krueger, T. Westenfeld, R. Schurgers, L. Brandenburg, V. Coagulation meets calcification: the vitamin K system. Int J Artif Organs. 2009 Feb; 32 (2): 67-74.
  30. Schurgers, L. J. Dissel, P. E. Spronk, H. M. Soute, B. A. Dhore, C. R. Cleutjens, J. P. Vermeer, C. Role of vitamin K and vitamin K-dependent proteins in vascular calcification. Z Kardiol. 2001; 90 Suppl 357-63.
  31. Wallin, R. Schurgers, L. Wajih, N. Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification. Thromb Res. 2008; 122 (3): 411-7.
  32. Tanaka, K. Kuwabara, A. [Fat soluble vitamins for maintaining bone health]. Clin Calcium. 2009 Sep; 19 (9): 1354-60.
  33. Schaafsma, A. Muskiet, F. A. Storm, H. Hofstede, G. J. Pakan, I. Van der Veer, E. Vitamin D(3) and vitamin K(1) supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. Eur J Clin Nutr. 2000 Aug; 54 (8): 626-31.
  34. Okano, T. [Vitamin D, K and bone mineral density]. Clin Calcium. 2005 Sep; 15 (9): 1489-94.
  35. Bolton-Smith, C. McMurdo, M. E. Paterson, C. R. Mole, P. A. Harvey, J. M. Fenton, S. T. Prynne, C. J. Mishra, G. D. Shearer, M. J. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J Bone Miner Res. 2007 Apr; 22 (4): 509-19.
  36. Panis, B. Vermeer, C. van Kroonenburgh, M. J. Nieman, F. H. Menheere, P. P. Spaapen, L. J. Rubio-Gozalbo, M. E. Effect of calcium, vitamins K1 and D3 on bone in galactosemia. Bone. 2006 Nov; 39 (5): 1123-9.
  37. Israels, L. G. Israels, E. D. Saxena, S. P. The riddle of vitamin K1 deficit in the newborn. Semin Perinatol. 1997 Feb; 21 (1): 90-6.
  38. Tsugawa, N. Shiraki, M. Suhara, Y. Kamao, M. Tanaka, K. Okano, T. Vitamin K status of healthy Japanese women: age-related vitamin K requirement for gamma-carboxylation of osteocalcin. Am J Clin Nutr. 2006 Feb; 83 (2): 380-6.
  39. Askim, M. [Vitamin K in the Norwegian diet and osteoporosis]. Tidsskr Nor Laegeforen. 2001 Sep 20; 121 (22): 2614-6.
  40. Vermeer, C. Shearer, M. J. Zittermann, A. Bolton-Smith, C. Szulc, P. Hodges, S. Walter, P. Rambeck, W. Stocklin, E. Weber, P. Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr. 2004 Dec; 43 (6): 325-35.
  41. Cranenburg, E. C. Schurgers, L. J. Vermeer, C. Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost. 2007 Jul; 98 (1): 120-5.
  42. McCann, J. C. Ames, B. N. Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging?. Am J Clin Nutr. 2009 Oct; 90 (4): 889-907.
  43. Tsugawa, N. Shiraki, M. Suhara, Y. Kamao, M. Ozaki, R. Tanaka, K. Okano, T. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab. 2008; 26 (1): 79-85.
  44. Wallin, R. Wajih, N. Greenwood, G. T. Sane, D. C. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev. 2001 Jul; 21 (4): 274-301.
  45. Lurie, Y. Loebstein, R. Kurnik, D. Almog, S. Halkin, H. Warfarin and vitamin K intake in the era of pharmacogenetics. Br J Clin Pharmacol. 2010 Aug; 70 (2): 164-70.
  46. Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood. 2007 Mar 15; 109 (6): 2419-23.
  47. Ford, S. K. Moll, S. Vitamin K supplementation to decrease variability of International Normalized Ratio in patients on vitamin K antagonists: a literature review. Curr Opin Hematol. 2008 Sep; 15 (5): 504-8.
  48. Rombouts, E. K. Rosendaal, F. R. Van Der Meer, F. J. Daily vitamin K supplementation improves anticoagulant stability. J Thromb Haemost. 2007 Oct; 5 (10): 2043-8.
  49. Booth, S. L. Dietary vitamin K guidance: an effective strategy for stable control of oral anticoagulation?. Nutr Rev. 2010 Mar; 68 (3): 178-81.

*These statements have not been evaluated by the Food and Drug Administration. The products and information presented on this website are not intended to diagnose, treat, cure, or prevent any disease.